SB Bioscience

SB Bioscience is a pharmaceutical firm that creates new medications and diagnostics using aptamer-based diagnostic signal amplification.

SB Bioscience operates in biotechnology, health care, health diagnostics, pharmaceutical based in Asia-Pacific (APAC), founded in 2020.

The company sits in the biotechnology, health care, health diagnostics, pharmaceutical segment, where it competes on its core product or service.

The business is associated with Asia-Pacific (APAC).

Its current recorded stage is Non_Equity_Assistance.

Website: www.sbbioscience.com